The agreement now includes distribution of Roche's Kapa Biosystems portfolio in all geographies except the US, Brazil, and Japan.
Under the terms of the deal, Color Genomics will integrate Kapa Biosystems' library construction reagents into its NGS workflow.
The certification enables the reagent maker to create optimizing products for use beyond the research market.
Kapa offers "essential components" to Roche's overall NGS solution and enables Roche to improve the workflow of its NGS platforms.
Roche said the acquisition will strengthen its next-generation sequencing product offerings.
Kapa will supply DNA library prep reagents for 10X's GemCode platform to enable a more streamlined workflow and higher quality sequencing data.
Kapa will manufacture versions of its RNA-seq kits for distribution with Roche's RNA target enrichment system.
The firm will transition from its current partnership with Anachem to a direct sales and support channel in the UK as it expands its European operations.
NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.